RPT-U.S. FDA approves biosimilar version of cancer drug Avastin
September 14, 2017 at 14:09 PM EDT
Sept 14 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.